The Gerald L. Klerman Award is the highest honor that DBSA gives to members of the scientific community. Presented each year, this award recognizes researchers whose work advances knowledge of the causes, diagnosis, and treatment of depression and bipolar disorder. Up to two awards are given annually in each of the following two categories: DBSA Gerald L. Klerman Award, Senior Investigator and DBSA Gerald L. Klerman Award, Young Investigator.
Gerald L. Klerman (1928-1992) was an educator, researcher, clinician, author, and administrator who specialized in depression, schizophrenia, and panic and other anxiety disorders. He was also one of DBSA’s earliest supporters. Klerman conducted the first clinical trial showing the efficacy of medication and psychotherapy in preventing recurrent depression and led the first large-scale, multi-site study to understand the diagnosis, course, and genetics of major depression
From 1966 to 1970 Klerman served on the faculty at Yale University. He subsequently moved to Harvard University where he taught at the medical school and was director of psychiatric research at Massachusetts General Hospital, as well as director of the Eric Lindemann Mental Health Center. He was appointed head of the Alcohol, Drug Abuse and Mental Health Administration from 1977 to 1980 by President Jimmy Carter, and then became professor of psychiatry and vice chairman of research at Cornell Medical College and New York Hospital. He was the author of numerous articles and books.
Nominations for the 2020-2021 Klerman Awards are now open
DBSA is now accepting nominations for the 2020-2021 Gerald L. Klerman Senior Investigator and Young Investigator awards. Please submit all nominations by July 15, 2021.